Wright Medical Group N.V. (NASDAQ:WMGI) had its target price trimmed by BMO Capital Markets from $34.00 to $31.00 in a report released on Thursday morning. They currently have an outperform rating on the medical device company’s stock.

WMGI has been the topic of several other reports. Needham & Company LLC restated a hold rating on shares of Wright Medical Group N.V. in a research note on Thursday. Jefferies Group LLC restated a buy rating and issued a $33.00 price target on shares of Wright Medical Group N.V. in a research note on Thursday, October 12th. Robert W. Baird restated a buy rating and issued a $33.00 price target on shares of Wright Medical Group N.V. in a research note on Friday, October 6th. Royal Bank Of Canada restated a buy rating and issued a $31.00 price target on shares of Wright Medical Group N.V. in a research note on Tuesday, October 3rd. Finally, BidaskClub upgraded shares of Wright Medical Group N.V. from a sell rating to a hold rating in a research note on Friday, August 11th. Six equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Wright Medical Group N.V. currently has an average rating of Buy and an average target price of $32.22.

Wright Medical Group N.V. (NASDAQ:WMGI) opened at $24.56 on Thursday. Wright Medical Group N.V. has a fifty-two week low of $20.69 and a fifty-two week high of $31.53. The company has a debt-to-equity ratio of 1.52, a quick ratio of 0.96 and a current ratio of 1.31.

Wright Medical Group N.V. (NASDAQ:WMGI) last released its quarterly earnings data on Wednesday, November 1st. The medical device company reported ($0.16) EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.16). Wright Medical Group N.V. had a negative net margin of 38.40% and a negative return on equity of 6.27%. The firm had revenue of $170.50 million for the quarter, compared to the consensus estimate of $173.50 million. During the same period in the previous year, the company earned ($0.19) earnings per share. The company’s quarterly revenue was up 8.4% on a year-over-year basis. analysts forecast that Wright Medical Group N.V. will post -0.28 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This news story was posted by Watch List News and is the property of of Watch List News. If you are accessing this news story on another website, it was stolen and republished in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://www.watchlistnews.com/wright-medical-group-n-v-wmgi-given-new-31-00-price-target-at-bmo-capital-markets/1682472.html.

A number of institutional investors have recently made changes to their positions in the business. Amalgamated Bank grew its stake in Wright Medical Group N.V. by 2.0% during the second quarter. Amalgamated Bank now owns 13,229 shares of the medical device company’s stock worth $364,000 after buying an additional 264 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Wright Medical Group N.V. by 11.6% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,797 shares of the medical device company’s stock worth $104,000 after buying an additional 396 shares in the last quarter. Teacher Retirement System of Texas grew its stake in Wright Medical Group N.V. by 6.8% during the second quarter. Teacher Retirement System of Texas now owns 7,884 shares of the medical device company’s stock worth $217,000 after buying an additional 502 shares in the last quarter. Legal & General Group Plc grew its stake in Wright Medical Group N.V. by 1.7% during the second quarter. Legal & General Group Plc now owns 36,752 shares of the medical device company’s stock worth $1,009,000 after buying an additional 597 shares in the last quarter. Finally, Prudential Financial Inc. grew its stake in Wright Medical Group N.V. by 9.1% during the second quarter. Prudential Financial Inc. now owns 7,678 shares of the medical device company’s stock worth $211,000 after buying an additional 640 shares in the last quarter.

About Wright Medical Group N.V.

Wright Medical Group, Inc is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic.

Analyst Recommendations for Wright Medical Group N.V. (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.